Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of Cannabinoid Drugs on Aversive or Rewarding Drug-Associated Memory Extinction and Reconsolidation
Cristina Aparecida Jark Stern, Cristiane Ribeiro de Carvalho, Leandro J. Bertoglio, et al.
Neuroscience (2017) Vol. 370, pp. 62-80
Closed Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Cannabidiol (CBD) use in psychiatric disorders: A systematic review
Stefania Bonaccorso, A Ricciardi, Caroline Zangani, et al.
NeuroToxicology (2019) Vol. 74, pp. 282-298
Open Access | Times Cited: 142
The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder
Yann Chye, Erynn Christensen, Nadia Solowij, et al.
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 119
Cannabidiol Treatment Might Promote Resilience to Cocaine and Methamphetamine Use Disorders: A Review of Possible Mechanisms
Claudia Calpe-López, María Pilar García-Pardo, M.A. Aguilar
Molecules (2019) Vol. 24, Iss. 14, pp. 2583-2583
Open Access | Times Cited: 70
Cannabinoid interventions for PTSD: Where to next?
Luke J. Ney, Allison Matthews, Raimondo Bruno, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2019) Vol. 93, pp. 124-140
Closed Access | Times Cited: 61
A scoping review of the use of cannabidiol in psychiatric disorders
Anna E. Kirkland, Matthew C. Fadus, Staci A. Gruber, et al.
Psychiatry Research (2021) Vol. 308, pp. 114347-114347
Open Access | Times Cited: 48
Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders
Ewa Galaj, Zheng‐Xiong Xi
CNS Drugs (2019) Vol. 33, Iss. 10, pp. 1001-1030
Open Access | Times Cited: 50
Reconsolidation blockade for the treatment of addiction: challenges, new targets, and opportunities
Marc T. J. Exton-McGuinness, Amy Milton
Learning & Memory (2018) Vol. 25, Iss. 9, pp. 492-500
Open Access | Times Cited: 45
Cannabidiol attenuates fear memory expression in female rats via hippocampal 5-HT1A but not CB1 or CB2 receptors
Jaqueline Maisa Franzen, Isabel Werle, Felipe Vanz, et al.
Neuropharmacology (2022) Vol. 223, pp. 109316-109316
Closed Access | Times Cited: 19
Female but not male rats show biphasic effects of low doses of Δ9-tetrahydrocannabinol on anxiety: can cannabidiol interfere with these effects?
Beatriz Zanutto Salviato, Ana Maria Raymundi, Thiago Rodrigues da Silva, et al.
Neuropharmacology (2021) Vol. 196, pp. 108684-108684
Closed Access | Times Cited: 23
Interaction Between Stress and Addiction: Contributions From Latin-American Neuroscience
Angélica Torres‐Berrío, Santiago Cuesta, Silvia López-Guzmán, et al.
Frontiers in Psychology (2018) Vol. 9
Open Access | Times Cited: 30
Evaluation of the potential use of cannabidiol in the treatment of cocaine use disorder: A systematic review
Larissa Alencar Rodrigues, Mariana Emanuele Silva Caroba, Fernando Kengy Taba, et al.
Pharmacology Biochemistry and Behavior (2020) Vol. 196, pp. 172982-172982
Open Access | Times Cited: 26
Effect of long-term cannabidiol on learning and anxiety in a female Alzheimer’s disease mouse model
Rose Chesworth, David Cheng, Chloe Staub, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 15
Cannabidiol (CBD) reduces cocaine-environment memory in mice
Rose Chesworth, Tim Karl
Pharmacology Biochemistry and Behavior (2020) Vol. 199, pp. 173065-173065
Closed Access | Times Cited: 23
CB1 Receptor Signaling Modulates Amygdalar Plasticity during Context-Cocaine Memory Reconsolidation to Promote Subsequent Cocaine Seeking
Jessica A. Higginbotham, Rong Wang, B. D. Richardson, et al.
Journal of Neuroscience (2020) Vol. 41, Iss. 4, pp. 613-629
Open Access | Times Cited: 21
Medial prefrontal cortex mechanisms of cannabidiol-induced aversive memory reconsolidation impairments
Hugo Bayer, Cristina Aparecida Jark Stern, Fernanda Troyner, et al.
Neuropharmacology (2021) Vol. 205, pp. 108913-108913
Closed Access | Times Cited: 18
Negative allosteric modulation of CB1 cannabinoid receptor signaling suppresses opioid-mediated reward
Vishakh Iyer, Claudia Rangel‐Barajas, Taylor J. Woodward, et al.
Pharmacological Research (2022) Vol. 185, pp. 106474-106474
Open Access | Times Cited: 12
Hippocampal D1-like dopamine receptor as a novel target for the effect of cannabidiol on extinction and reinstatement of methamphetamine-induced CPP
Amir Mohammad Farrokhi, Fazel Moshrefi, Kiarash Eskandari, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 133, pp. 111025-111025
Closed Access | Times Cited: 2
Unveiling the Potential of Phytocannabinoids: Exploring Marijuana’s Lesser-Known Constituents for Neurological Disorders
Balapal S. Basavarajappa, Shivakumar Subbanna
Biomolecules (2024) Vol. 14, Iss. 10, pp. 1296-1296
Open Access | Times Cited: 2
From an Alternative Medicine to a New Treatment for Refractory Epilepsies: Can Cannabidiol Follow the Same Path to Treat Neuropsychiatric Disorders?
Rafael Mariano de Bitencourt, Reinaldo Ν. Takahashi, E.A. Carlini
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 16
Cannabidiol Produces Distinct U-Shaped Dose-Response Effects on Cocaine-Induced Conditioned Place Preference and Associated Recruitment of Prelimbic Neurons in Male Rats
Hermina Nedelescu, Grant E. Wagner, Genna L. De Ness, et al.
Biological Psychiatry Global Open Science (2021) Vol. 2, Iss. 1, pp. 70-78
Open Access | Times Cited: 14
Therapeutic potential of PIMSR, a novel CB1 receptor neutral antagonist, for cocaine use disorder: evidence from preclinical research
Ewa Galaj, Briana J. Hempel, Allamar Moore, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 10
Pharmacological interventions during the process of reconsolidation of aversive memories: A systematic review
Lívia Maria Bolsoni, Antônio Waldo Zuardi
Neurobiology of Stress (2019) Vol. 11, pp. 100194-100194
Open Access | Times Cited: 16
DNA methyltransferase activity in the basolateral amygdala is critical for reconsolidation of a heroin reward memory
Shuyi Qian, Cuijie Shi, Shihao Huang, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 9
Comparison of cannabidiol to citalopram in targeting fear memory in female mice
Zackary T. Montoya, Amy L. Uhernik, Jeffrey Smith
Journal of Cannabis Research (2020) Vol. 2, Iss. 1
Open Access | Times Cited: 14
Cannabidiol impairs fear memory reconsolidation in female rats through dorsal hippocampus CB1 but not CB2 receptor interaction
Jaqueline Maisa Franzen, Felipe Vanz, Isabel Werle, et al.
European Neuropsychopharmacology (2022) Vol. 64, pp. 7-18
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top